Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Genitourinary 1

Conditions

Carcinoma, Renal Cell 65Neoplasms 10Neoplasm Metastasis 9Kidney Neoplasms 7Prostatic Neoplasms 5Urinary Bladder Neoplasms 4Sarcoma 4Clear-cell metastatic renal cell carcinoma 4Breast Neoplasms 4Pancreatic Neoplasms 3Ovarian Neoplasms 3Melanoma 2Financial Stress 2Carcinoma, Non-Small-Cell Lung 2Wilms Tumor 1Uterine Cervical Neoplasms 1Urethral Neoplasms 1Thyroid Neoplasms 1Testicular Neoplasms 1Small Cell Lung Carcinoma 1Patient Preference 1Pathologic Complete Response 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Osteosarcoma 1Oncocytoma, renal 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms, Germ Cell and Embryonal 1Lung Neoplasms 1Liver Neoplasms 1

Interventions

Cyclophosphamide 7fludarabine phosphate 4Flow Cytometry 4Busulfan 4Antilymphocyte Serum 4Tacrolimus 3Peripheral Blood Stem Cell Transplantation 3Mycophenolic Acid 3Whole-Body Irradiation 2Thiotepa 2Radiotherapy 2Methylprednisolone 2Methotrexate 2Melphalan 2Immunologic Techniques 2Filgrastim 2Etoposide 2Cyclosporine 2Carmustine 2Carboplatin 2Alemtuzumab 2thymoglobulin 1sargramostim 1resiquimod 1poly ICLC 1pazopanib 1orantinib 1motexafin gadolinium 1fludarabine 1dexamethasone acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × pazopanib × Genitourinary × Clear all
NCT00256880 2017-01-18

Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma

GlaxoSmithKline

Phase 2 Completed
100 enrolled
GenitourinaryPlasma cell

Carcinoma, Renal Cell, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡